Scott Potter

789 total citations
15 papers, 649 citations indexed

About

Scott Potter is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Scott Potter has authored 15 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Biochemistry. Recurrent topics in Scott Potter's work include Cancer, Hypoxia, and Metabolism (6 papers), Biochemical and Molecular Research (5 papers) and Biochemical Acid Research Studies (4 papers). Scott Potter is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Biochemical and Molecular Research (5 papers) and Biochemical Acid Research Studies (4 papers). Scott Potter collaborates with scholars based in United States. Scott Potter's co-authors include Paul D. van Poelje, Mark D. Erion, Qun Dang, Srinivas Rao Kasibhatla, Tao Jiang, K. Raja Reddy, M. Rami Reddy, William N. Lipscomb, Tony Gibson and Yan Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Scott Potter

14 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott Potter United States	9	348	233	139	97	67	15	649
Thomas Pauly United States	10	388 1.1×	94 0.4×	85 0.6×	63 0.6×	39 0.6×	22	603
Sheldon N. Crane Canada	13	232 0.7×	195 0.8×	53 0.4×	17 0.2×	41 0.6×	18	451
Catherine Sekerke United States	16	278 0.8×	222 1.0×	67 0.5×	41 0.4×	201 3.0×	19	645
David R. Magnin United States	14	332 1.0×	367 1.6×	50 0.4×	46 0.5×	81 1.2×	21	736
Daniela Piras Italy	10	184 0.5×	179 0.8×	117 0.8×	38 0.4×	62 0.9×	21	479
Toshiaki Sakamoto Japan	13	331 1.0×	306 1.3×	32 0.2×	215 2.2×	130 1.9×	29	701
Mengxiao Shi United States	13	277 0.8×	173 0.7×	21 0.2×	25 0.3×	32 0.5×	20	536
Tomomi Noguchi‐Yachide Japan	17	332 1.0×	208 0.9×	27 0.2×	30 0.3×	95 1.4×	36	631
Roger P. Dickinson United Kingdom	15	215 0.6×	266 1.1×	105 0.8×	16 0.2×	31 0.5×	26	636
Jessica E. Friedman United States	6	331 1.0×	101 0.4×	58 0.4×	38 0.4×	9 0.1×	7	625

Countries citing papers authored by Scott Potter

Since Specialization

Citations

This map shows the geographic impact of Scott Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Potter more than expected).

Fields of papers citing papers by Scott Potter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Potter. The network helps show where Scott Potter may publish in the future.

Co-authorship network of co-authors of Scott Potter

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Potter. A scholar is included among the top collaborators of Scott Potter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Potter. Scott Potter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Köester, Anja, Derrick R. Witcher, Mark Lee, et al.. (2025). Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study. Nature Communications. 16(1). 4082–4082. 1 indexed citations

White, Sandra, Brandon S. Walker, Scott Potter, David I. Anderson, & Ryan A. Metcalf. (2025). Estimating the incidence of transfusion‐associated circulatory overload using active surveillance: A systematic review and meta‐analysis. Transfusion. 65(6). 1061–1071.

Feng, Yiqing, et al.. (2024). PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity. Journal of Autoimmunity. 149. 103339–103339. 3 indexed citations

Potter, Scott, et al.. (2023). A pleomorphic xanthoastrocytoma highlighting the morphological heterogeneity of this uncommon tumor. Journal of Neuropathology & Experimental Neurology. 83(1). 61–64. 1 indexed citations

Potter, Scott, et al.. (2022). Mechanics of lung cancer: A finite element model shows strain amplification during early tumorigenesis. PLoS Computational Biology. 18(10). e1010153–e1010153. 2 indexed citations

Metcalf, Ryan A., Sandra White, Scott Potter, et al.. (2019). The association of inpatient blood utilization and diagnosis‐related group weight: implications for risk‐adjusted benchmarking. Transfusion. 59(7). 2316–2323. 1 indexed citations

Poelje, Paul D. van, Scott Potter, & Mark D. Erion. (2011). Fructose-1, 6-Bisphosphatase Inhibitors for Reducing Excessive Endogenous Glucose Production in Type 2 Diabetes. Handbook of experimental pharmacology. 279–301. 52 indexed citations

Dang, Qun, Tao Jiang, Tony Gibson, et al.. (2011). Oxazole phosphonic acids as fructose 1,6-bisphosphatase inhibitors with potent glucose-lowering activity. MedChemComm. 2(4). 287–290. 16 indexed citations

Dang, Qun, Yan Liu, Daniel K. Cashion, et al.. (2010). Discovery of a Series of Phosphonic Acid-Containing Thiazoles and Orally Bioavailable Diamide Prodrugs That Lower Glucose in Diabetic Animals Through Inhibition of Fructose-1,6-Bisphosphatase. Journal of Medicinal Chemistry. 54(1). 153–165. 141 indexed citations

10.

Dang, Qun, Srinivas Rao Kasibhatla, Wei Xiao, et al.. (2009). Fructose-1,6-bisphosphatase Inhibitors. 2. Design, Synthesis, and Structure−Activity Relationship of a Series of Phosphonic Acid Containing Benzimidazoles that Function as 5′-Adenosinemonophosphate (AMP) Mimics. Journal of Medicinal Chemistry. 53(1). 441–451. 61 indexed citations

11.

Dang, Qun, Srinivas Rao Kasibhatla, Tao Jiang, et al.. (2008). Discovery of Phosphonic Diamide Prodrugs and Their Use for the Oral Delivery of a Series of Fructose 1,6-Bisphosphatase Inhibitors. Journal of Medicinal Chemistry. 51(14). 4331–4339. 46 indexed citations

12.

Dang, Qun, Srinivas Rao Kasibhatla, K. Raja Reddy, et al.. (2007). Discovery of Potent and Specific Fructose-1,6-Bisphosphatase Inhibitors and a Series of Orally-Bioavailable Phosphoramidase-Sensitive Prodrugs for the Treatment of Type 2 Diabetes. Journal of the American Chemical Society. 129(50). 15491–15502. 84 indexed citations

13.

Poelje, Paul D. van, Scott Potter, Visvanathan Chandramouli, et al.. (2006). Inhibition of Fructose 1,6-Bisphosphatase Reduces Excessive Endogenous Glucose Production and Attenuates Hyperglycemia in Zucker Diabetic Fatty Rats. Diabetes. 55(6). 1747–1754. 68 indexed citations

14.

Erion, Mark D., Paul D. van Poelje, Qun Dang, et al.. (2005). MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes. Proceedings of the National Academy of Sciences. 102(22). 7970–7975. 139 indexed citations

15.

Young, Mark A., et al.. (1994). Characterization of arbutamine: A novel catecholamine stress agent for diagnosis of coronary artery disease. Drug Development Research. 32(1). 19–28. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact